IFF’s Pharma Solutions offers more than polymers designed for controlled release. We offer unique products to reduce manufacturing complexity to save you time and money. Designed morphology excipients, like METHOCEL™ DC2, can streamline matrix tablet production by bypassing costly wet granulation and drying steps. Moreover, our range of ethylcellulose based products, including water-based technologies and dry-powder coatings, allow you to tailor your barrier membrane coating system for optimal flexibility.
IFF’s controlled release technologies surpass conventional matrix tablets. Our expertise extends to formulating multiparticulate drug-delivery systems with barrier membrane coatings, osmotic pump tablets, gastro-retentive formulations and more. Our technical experts around the globe are ready to help you on your formulation journey.
Technology | Application | Recommended Products |
|---|---|---|
Multiparticles | Substrate | Avicel® PH spheres produced via extrusion spheronization |
Drug layering binder | METHOCEL™ E3, E5, E6 or VLV Premium | |
Modified release Solvent Based | ETHOCEL™ Std 4, 7, 10, 14 Premium | |
Water Based | Aquacoat® ECD-30, CPD-30 | |
Dry Powder | ETHOCEL™ HP | |
Coascervation | ETHOCEL™ Std 45, 100 Premium | |
Tableting cushioning compression aid | Avicel® PH 200, 200 LM Avicel® SMCC 90, 90 HD | |
Matrices | CR Matrix Former | METHOCEL™ K100 PRM LV, K4M PRM, K100M PRM, E4M PRM POLYOX™ N60K NF, 301 NF, Coagulant NF, 303 NF ETHOCEL™ STD PRM FP products Protanal® CR 8133 and 8233, Manucol® LKX |
Osmotic Pump Tablets | Push Layer Swelling Polymer | POLYOX™ 301 NF, Coagulant NF, 303 NF |
Drug Layer Drug Dispersant | POLYOX™ N10 NF, N80 NF |
*Examples only and not representative of a complete list of recommended products or benefits.
Learn more about how we can support your formulation.
Learn more about how we can support your formulation.
